PATRICIA: A Phase II Clinical Trial of Combined Palbociclib and Trastuzumab, With or Without Letrozole, in Post-menopausal Patients With Previously-treated Locally Advanced or Metastatic HER2-positive Breast Cancer

Trial Profile

PATRICIA: A Phase II Clinical Trial of Combined Palbociclib and Trastuzumab, With or Without Letrozole, in Post-menopausal Patients With Previously-treated Locally Advanced or Metastatic HER2-positive Breast Cancer

Recruiting
Phase of Trial: Phase II

Latest Information Update: 24 Dec 2016

At a glance

  • Drugs Palbociclib (Primary) ; Letrozole; Trastuzumab
  • Indications Advanced breast cancer
  • Focus Therapeutic Use
  • Acronyms PATRICIA
  • Most Recent Events

    • 05 Aug 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
    • 25 May 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top